The comparative clinical pharmacology of vincristine and vindesine: Does vindesine offer any advantage in clinical use?

被引:22
作者
Joel, S
机构
[1] Medical Oncology Department, St Bartholomew's Hospital, London
关键词
D O I
10.1016/0305-7372(95)90015-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:513 / 525
页数:13
相关论文
共 76 条
[71]  
WALKER BK, 1982, CANCER TREAT REP, V66, P1729
[72]  
WEICK J, 1984, CANCER TREAT REP, V68, P7
[73]   OVER-EXPRESSION OF P-GLYCOPROTEIN AND GLUTATHIONE-S-TRANSFERASE-PI IN MCF-7 CELLS SELECTED FOR VINCRISTINE RESISTANCE INVITRO [J].
WHELAN, RDH ;
WARING, CJ ;
WOLF, CR ;
HAYES, JD ;
HOSKING, LK ;
HILL, BT .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (02) :241-246
[74]   COMBINATION CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) [J].
WOODRUFF, RK ;
LISTER, TA ;
PAXTON, AM ;
WHITEHOUSE, JMA ;
MALPAS, JS .
AMERICAN JOURNAL OF HEMATOLOGY, 1978, 4 (02) :173-177
[75]  
YAP HY, 1981, CANCER TREAT REP, V65, P775
[76]  
ZHOU XJ, 1992, DRUGS, V1, P1